Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Profound Medical price target raised to $18 from $15 at Alliance Global Partners » 08:12
08/07/20
08/07
08:12
08/07/20
08:12
PROF

Profound Medical

$15.16 /

-0.78 (-4.89%)

Alliance Global Partners…

Alliance Global Partners analyst Ben Haynor raised the firm's price target on Profound Medical to $18 from $15 and reiterates a Buy rating on the shares following the company's better than expected Q2 results. The COVID-19 pandemic continues to impact new installs, but Profound's procedure volumes at already installed sites appear to be running ahead of management's expectations, Haynor tells investors in a research note. The analyst came away from the earnings call "quite encouraged" by the U.S. reception to TULSA-PRO.

ShowHide Related Items >><<
PROF Profound Medical
$15.16 /

-0.78 (-4.89%)

07/31/20 Raymond James
Profound Medical price target raised to C$43 from C$38 at Raymond James
06/26/20 Raymond James
Profound Medical price target raised to C$38 from C$35 at Raymond James
04/07/20 Mackie
Profound Medical downgraded to Hold from Buy at Mackie
04/01/20
Fly Intel: Top five analyst initiations
  • 16
    Jul
  • 22
    Jan
Over a week ago
Recommendations
Profound Medical price target raised to C$43 from C$38 at Raymond James » 11:44
07/31/20
07/31
11:44
07/31/20
11:44
PROF

Profound Medical

$15.15 /

-0.06 (-0.39%)

Raymond James analyst…

Raymond James analyst Rahul Sarugaser raised the firm's price target on Profound Medical to C$43 from C$38 and keeps a Strong Buy rating on the shares.

ShowHide Related Items >><<
PROF Profound Medical
$15.15 /

-0.06 (-0.39%)

PROF Profound Medical
$15.15 /

-0.06 (-0.39%)

06/26/20 Raymond James
Profound Medical price target raised to C$38 from C$35 at Raymond James
04/07/20 Mackie
Profound Medical downgraded to Hold from Buy at Mackie
04/01/20
Fly Intel: Top five analyst initiations
04/01/20 Cowen
Profound Medical initiated with an Outperform at Cowen
  • 16
    Jul
  • 22
    Jan
Syndicate
Profound Medical 2.76M share Spot Secondary priced at $14.50 » 21:00
07/15/20
07/15
21:00
07/15/20
21:00
PROF

Profound Medical

$16.24 /

-0.53 (-3.16%)

The deal priced below the…

The deal priced below the last closing price of $16.23. Jefferies, Cowen and Raymond James are acting as joint book running managers for the offering.

ShowHide Related Items >><<
PROF Profound Medical
$16.24 /

-0.53 (-3.16%)

PROF Profound Medical
$16.24 /

-0.53 (-3.16%)

06/26/20 Raymond James
Profound Medical price target raised to C$38 from C$35 at Raymond James
04/07/20 Mackie
Profound Medical downgraded to Hold from Buy at Mackie
04/01/20
Fly Intel: Top five analyst initiations
04/01/20 Cowen
Profound Medical initiated with an Outperform at Cowen
  • 16
    Jul
  • 22
    Jan
Syndicate
Profound Medical announces offering of common shares, no amount given » 16:06
07/15/20
07/15
16:06
07/15/20
16:06
PROF

Profound Medical

$16.28 /

-0.49 (-2.92%)

Profound Medical Corp.…

Profound Medical Corp. announced that it intends to file a preliminary prospectus supplement to its short form base shelf prospectus dated October 17, 2019 in the United States and Canada relating to a proposed marketed public offering of common shares of the company. The offering will be priced in the context of the market with such price and the total size of the offering to be determined at the time of entering into an underwriting agreement with respect thereto. The net proceeds of the offering are expected to be used: (i) to fund the commercial launch of TULSA-PRO in the United States and the continued development and commercialization of TULSA-PRO and SONALLEVE globally; and (ii) for working capital and general corporate purposes. Jefferies, Cowen, and Raymond James are acting as joint book-running managers for the offering.

ShowHide Related Items >><<
PROF Profound Medical
$16.28 /

-0.49 (-2.92%)

PROF Profound Medical
$16.28 /

-0.49 (-2.92%)

06/26/20 Raymond James
Profound Medical price target raised to C$38 from C$35 at Raymond James
04/07/20 Mackie
Profound Medical downgraded to Hold from Buy at Mackie
04/01/20
Fly Intel: Top five analyst initiations
04/01/20 Cowen
Profound Medical initiated with an Outperform at Cowen
  • 22
    Jan
Over a month ago
Recommendations
Profound Medical price target raised to C$38 from C$35 at Raymond James » 10:41
06/26/20
06/26
10:41
06/26/20
10:41
PROF

Profound Medical

$14.51 /

+0.17 (+1.19%)

Raymond James analyst…

Raymond James analyst Rahul Sarugaser raised the firm's price target on Profound Medical to C$38 from C$35 and keeps a Strong Buy rating on the shares.

ShowHide Related Items >><<
PROF Profound Medical
$14.51 /

+0.17 (+1.19%)

PROF Profound Medical
$14.51 /

+0.17 (+1.19%)

04/07/20 Mackie
Profound Medical downgraded to Hold from Buy at Mackie
04/01/20
Fly Intel: Top five analyst initiations
04/01/20 Cowen
Profound Medical initiated with an Outperform at Cowen
01/27/20 Raymond James
Profound Medical upgraded to Strong Buy from Outperform at Raymond James
PROF Profound Medical
$14.51 /

+0.17 (+1.19%)

  • 22
    Jan
Over a quarter ago
Downgrade
Profound Medical downgraded to Hold from Buy at Mackie » 09:02
04/07/20
04/07
09:02
04/07/20
09:02
PROF

Profound Medical

$10.43 /

+0.57 (+5.78%)

Mackie analyst Andre…

Mackie analyst Andre Uddin downgraded Profound Medical to Hold from Buy with a C$16.20 price target.

ShowHide Related Items >><<
PROF Profound Medical
$10.43 /

+0.57 (+5.78%)

04/01/20
Fly Intel: Top five analyst initiations
04/01/20 Cowen
Profound Medical initiated with an Outperform at Cowen
01/27/20 Raymond James
Profound Medical upgraded to Strong Buy from Outperform at Raymond James
Initiation
Fly Intel: Top five analyst initiations » 10:17
04/01/20
04/01
10:17
04/01/20
10:17
ZM

Zoom Video

$139.52 /

-6.56 (-4.49%)

, BTAI

BioXcel Therapeutics

$20.98 /

-1.42 (-6.34%)

, PROF

Profound Medical

$9.35 /

-0.25 (-2.60%)

, AEO

American Eagle

$7.16 /

-0.775 (-9.77%)

, HBI

Hanesbrands

$7.42 /

-0.44 (-5.60%)

, ESPR

Esperion

$30.89 /

-0.51 (-1.62%)

, KNSA

Kiniksa

$15.26 /

-0.16 (-1.04%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Zoom Video (ZM) initiated with a Neutral at DA Davidson. 2. BioXcel Therapeutics (BTAI) initiated with a Buy at BofA. 3. Profound Medical (PROF) initiated with an Outperform at Cowen. 4. American Eagle (AEO) and Hanesbrands (HBI) initiated with a Market Perform at Raymond James. 5. Esperion (ESPR) and Kiniksa (KNSA) initiated with a Buy at BofA. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
ZM Zoom Video
$139.52 /

-6.56 (-4.49%)

04/01/20
DA Davidson starts Zoom Video at Neutral citing 'rich valuation'
03/31/20 DA Davidson
Zoom Video initiated with a Neutral at DA Davidson
03/30/20 JPMorgan
Zoom Video users up 'staggering' 378% versus last year, says JPMorgan
03/26/20 Baird
Bandwidth added as a Fresh Pick at Baird
BTAI BioXcel Therapeutics
$20.98 /

-1.42 (-6.34%)

04/01/20 BofA
BioXcel Therapeutics initiated with a Buy at BofA
04/01/20 BofA
BioXcel Therapeutics initiated with a Buy at BofA
03/10/20 BMO Capital
BioXcel Therapeutics price target raised to $64 from $26 at BMO Capital
02/26/20 H.C. Wainwright
BioXcel Therapeutics price target raised to $95 from $30 at H.C. Wainwright
PROF Profound Medical
$9.35 /

-0.25 (-2.60%)

04/01/20 Cowen
Profound Medical initiated with an Outperform at Cowen
01/27/20 Raymond James
Profound Medical upgraded to Strong Buy from Outperform at Raymond James
AEO American Eagle
$7.16 /

-0.775 (-9.77%)

04/01/20 Raymond James
American Eagle initiated with a Market Perform at Raymond James
03/31/20 Raymond James
American Eagle initiated with a Market Perform at Raymond James
03/24/20 Wedbush
Microsoft, Alphabet among stocks in Wedbush's Shopping List
03/24/20 DA Davidson
American Eagle downgraded to Neutral from Buy at DA Davidson
HBI Hanesbrands
$7.42 /

-0.44 (-5.60%)

04/01/20 Raymond James
Hanesbrands initiated with a Market Perform at Raymond James
03/31/20 Raymond James
Hanesbrands initiated with a Market Perform at Raymond James
02/05/20 Stifel
Hanesbrands sentiment too cautious ahead of Q4 report, says Stifel
01/02/20
Fly Intel: Top five analyst downgrades
ESPR Esperion
$30.89 /

-0.51 (-1.62%)

04/01/20 BofA
Esperion initiated with a Buy at BofA
03/17/20 Citi
Citi upgrades Esperion to Buy on attractive valuation after pullback
03/17/20 Citi
Esperion upgraded to Buy from Neutral at Citi
02/27/20 JMP Securities
JMP reiterates $191 price target on Esperion after second FDA approval
KNSA Kiniksa
$15.26 /

-0.16 (-1.04%)

04/01/20 BofA
Kiniksa initiated with a Buy at BofA
12/06/19 Goldman Sachs
Kiniksa assumed to Buy from Neutral at Goldman Sachs
08/14/19 JMP Securities
Kiniksa price target lowered to $35 from $44 at JMP Securities
Initiation
Profound Medical initiated with an Outperform at Cowen » 06:54
04/01/20
04/01
06:54
04/01/20
06:54
PROF

Profound Medical

$9.60 /

-0.11 (-1.13%)

Cowen analyst Joshua…

Cowen analyst Joshua Jennings initiated coverage of Profound Medical with an Outperform rating and $15 price target. The company's TULSA-PRO, a proprietary platform that offers an incision-free alternative treatment option for prostate cancer, will see solid near-term demand from cash-pay patients and then experience a longer-term inflection driven by reimbursement coverage, Jennings tells investors in a research note. Further, the analyst does not expect COVID-19 to disrupt Profound's traction this year.

ShowHide Related Items >><<
PROF Profound Medical
$9.60 /

-0.11 (-1.13%)

01/27/20 Raymond James
Profound Medical upgraded to Strong Buy from Outperform at Raymond James
Hot Stocks
Profound Medical retires bank debt ahead of schedule » 16:32
02/04/20
02/04
16:32
02/04/20
16:32
PROF

Profound Medical

$17.15 /

+0.44 (+2.63%)

Profound Medical Corp.…

Profound Medical Corp. announced that it has retired its $12.5M in principal amount loan with Canadian Imperial Bank of Commerce, maturing on July 29, 2022.

ShowHide Related Items >><<
PROF Profound Medical
$17.15 /

+0.44 (+2.63%)

01/27/20 Raymond James
Profound Medical upgraded to Strong Buy from Outperform at Raymond James
Upgrade
Profound Medical upgraded to Strong Buy from Outperform at Raymond James » 13:18
01/27/20
01/27
13:18
01/27/20
13:18
PROF

Profound Medical

$12.05 /

-0.2 (-1.63%)

Raymond James analyst…

Raymond James analyst Rahul Sarugaser upgraded Profound Medical to Strong Buy from Outperform with a C$45 price target.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.